Form 8-K - Current report:
SEC Accession No. 0001683168-22-008422
Filing Date
2022-12-14
Accepted
2022-12-14 16:00:39
Documents
12
Period of Report
2022-12-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm   iXBRL 8-K 26290
  Complete submission text file 0001683168-22-008422.txt   199194

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cnsp-20221213.xsd EX-101.SCH 2962
3 XBRL LABEL FILE cnsp-20221213_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cnsp-20221213_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3718
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 221462068
SIC: 2834 Pharmaceutical Preparations